Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
Clinical trial NCT02698280 · COMPLETED
Trial details
- NCT number
- NCT02698280
- Sponsor
- Huashan Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-01-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.